| Project/Area Number |
25860865
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Pediatrics
|
|---|
| Research Institution | Okayama University |
|---|
Principal Investigator |
|
|---|
| Research Collaborator |
YAMADA Mutsuko 岡山大学, 大学院医歯薬学総合研究科・小児科, 非常勤研究員
FUJII Yousuke 岡山大学, 大学院医歯薬学総合研究科・小児科, 助教 (80549775)
NOSAKA Nobuyuki 岡山大学病院, 小児科, 医員 (30713961)
TSUKAHARA Hirokazu 岡山大学, 大学院医歯薬学総合研究科小児医科学, 教授 (90207340)
MORISHIMA Tsuneo 岡山大学, 大学院医歯薬学総合研究科小児医科学, 特命教授 (90157892)
|
|---|
| Project Period (FY) |
2013-04-01 – 2016-03-31
|
| Project Status |
Completed (Fiscal Year 2015)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2015: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | 小児感染症学 / インフルエンザ / 酸化ストレス |
|---|
| Outline of Final Research Achievements |
TBP2KO mouse was suggested possibility of a metabolic disorder type influenza encephalopathy (Reye syndrome) model mice. In addition redox-active protein of TRX and anti-HMGB1 antibody has been shown to be effective in severe influenza pneumonia in mice. It is expected to confirm the therapeutic effect using a drug with anti-oxidative and anti-inflammatory effect in encephalopathy model mice.
|
